PCRX
Pacira BioSciences, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -20.0% ·
Aktienfluss -12.2% ·
neue Nettopositionen -20.0%
— Formel
Breite Distribution — sinkende Anteile und weniger Halter
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 89 | +2 | 30.85M | $781.81M | +7 | −4 |
| Q1 2026 | 89 | -5 | 30.76M | $694.94M | +2 | −7 |
| Q4 2025 | 94 | -1 | 36.25M | $938.05M | — | −1 |
| Q3 2025 | 19 | +1 | 24.74M | $637.46M | +2 | −1 |
| Q2 2025 | 15 | 0 | 22.66M | $541.65M | +1 | −1 |
| Q1 2025 | 12 | -3 | 10.29M | $255.59M | — | −3 |
| Q4 2024 | 15 | +1 | 11.71M | $220.69M | +1 | — |
| Q3 2024 | 13 | 0 | 9.23M | $138.98M | +1 | −1 |
| Q2 2024 | 13 | — | 6.89M | $197.00M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | D. E. Shaw & Co. ✦ | 2.26M | +0.3% | $56.26M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | D. E. Shaw & Co. ✦ | 2.26M | +0.3% | $56.26M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 3 | D. E. Shaw & Co. ✦ | 2.26M | +0.3% | $56.26M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 2.24M | +12.4% | $55.68M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (passiv) | 1.98M | +0.7% | $49.19M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 1.33M | +2700.8% | $33.05M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 1.33M | +2700.8% | $33.05M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passiv) | 1.14M | +4.2% | $28.27M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passiv) | 1.14M | +4.2% | $28.27M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Wellington Management ✦ | 537.13K | +14.2% | $13.35M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Wellington Management ✦ | 537.13K | +14.2% | $13.35M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Wellington Management ✦ | 537.13K | +14.2% | $13.35M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Wellington Management ✦ | 537.13K | +14.2% | $13.35M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Wellington Management ✦ | 537.13K | +14.2% | $13.35M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Millennium Management ✦ | 345.62K | -76.7% | $8.59M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 176.78K | -38.7% | $4.39M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 176.78K | -38.7% | $4.39M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 176.78K | -38.7% | $4.39M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 176.78K | -38.7% | $4.39M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 118.34K | +3.2% | $2.94M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Arrowstreet Capital ✦ | 67.59K | -89.6% | $1.68M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | T. Rowe Price ✦ | 44.99K | +8.9% | $1.12M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 43.17K | -33.5% | $1.07M | 0.0% | ▼ Trim | 4 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Point72 Asset Management | $20.27M | war 0.1% |
| Norges Bank | $2.41M | war 0.0% |
| Marshall Wace | $802,830 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 3 Inhaber, 13.02M Anteile, $12.57M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.